🌍·8h agoIndustry
Bispecific and multi-specific antibody development journey at WuXi Biologics
Publisher
W
WuXi Biologics
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on wuxibiologics.com
Leave the platform to read the original full article on the publisher site.
Source: WuXi Biologics
Scope: Industry
Related coverage
More related coverage
Amarin Corporation·6h ago
AME และ AME Group ได้รับตราสัญลักษณ์มาตรฐานไมซ์ในงาน MICE Standards Day 2026
GH Research·14h ago
GH Research Announces Publication of Phase 2a Postpartum Depression Results
Fate Therapeutics·15h ago
FT839: A Multi-Antigen Targeting Off-the-Shelf Dual-CAR T Cell for the Treatment of Pathogenic B and T Cells in Autoimmune Diseases
Fate Therapeutics·15h ago